$49.41
-$0.49
(-0.98%)
Quote as of 4:00 PM EST on 02/09/12
United Therapeutics Corp
NASDAQ:UTHR
Extended Hours:
$49.41
$0.00
(0.00%)
Quote as of 4:27 PM EST on 02/09/12 (NASDAQ)
|
$49.41
-$0.49
(-0.98%)
|
|
| Today's Open | $49.60 |
|---|---|
| Previous Close | $49.90 |
| Daily Range | $48.72 - $49.60 |
| 52-Week Range | $36.55 - $70.74 |
| Market Cap | $2.88B |
| P/E Ratio | 16.92 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 980,713 |
| Average Daily Volume | 882,918 |
| Current FY EPS | $3.65 |
UTHR Information
| Description |
|---|
| A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
United Therapeutics Earnings Preview
Generic Challenge for UTHR's Remodulin - Analyst Blog
United Therapeutics Passes This Key Test
EU Nod for UTHR's Remodulin IV - Analyst Blog
United Therapeutics Corp - Aggressive Growth
Zacks Releases Four Powerful ''Buy'' Stocks: United Therapeutics, Monsanto, Universal and Genesco -
United Therapeutics Enters Oversold Territory - Tale of the Tape
United Therapeutics to Offer $210M in Debt
1 Reason the Street Should Love Gilead Sciences' Earnings
